Search results - 2 results
Vaccine effectiveness of the second and third COVID-19 boosters in Belgium (administered during 2022 autumn campaign)
meeting the definition of immunocompromised conditions (from January 24, 2022) and to people who had received the Jcovden vaccine (Johnson&Johnson®) as a primary COVID-19 vaccination schedule (from ...
Regulatory issues regarding manufacture and control of vaccine adjuvants. The EU situation.
Future Development, Meeting Management, Issue Herriot,J., Vanden Bossche,G., Lausanne, Switserland (2013) Keywords: a Activity additional ALL Aluminium an Antioxidant Antioxidants application AS assessment ...